Related Experiment Video
Updated: Aug 9, 2026
04:41
Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
Published on: March 10, 2023
[Liver transplantation for treating hepatocellular carcinoma]
Xiang-de Liu1, Zhan-yu Yang, Shu-guang Wang
1Hepatobiliary Surgery Institute of PLA, Southwest Hospital, Third Military Medical University, Chongqing 400038, China.
Summary
Orthotopic liver transplantation (OLT) outcomes for hepatocellular carcinoma (HCC) vary significantly by stage. Stage I and II HCC patients experience better long-term survival after OLT, highlighting the need for strict patient selection.
Area of Science:
- Hepatobiliary surgery
- Transplant surgery
- Surgical oncology
Context:
- Hepatocellular carcinoma (HCC) is a primary liver malignancy.
- Orthotopic liver transplantation (OLT) is a potential curative treatment for HCC.
- Patient selection is critical for successful OLT outcomes in HCC.
Purpose:
- To evaluate the efficacy of orthotopic liver transplantation (OLT) in treating hepatocellular carcinoma (HCC).
- To analyze survival rates of HCC patients undergoing OLT across different disease stages.
Summary:
- This study analyzed 92 OLTs for HCC between 1999 and 2005.
- Survival rates differed significantly by UICC TNM stage: Stage I (5-year: 50.0%), Stage II (3-year: 66.7%), Stage III (3-year: 0%), Stage IV (5-year: 5.0%).
- Long-term survival was primarily achieved in Stage I and II HCC patients.
Impact:
- Results indicate that OLT offers long-term survival for select HCC patients.
- Strict adherence to selection criteria for OLT in HCC is crucial for optimizing patient outcomes.
- This study informs clinical decision-making regarding OLT for hepatocellular carcinoma.
